Okładka

Ertugliflozin in the treatment of type 2 diabetes mellitus

More than 422 million people worldwide have diabetes, with 90-95% having type 2 diabetes (T2D). Glycemic control of T2D has demonstrated reductions in microvascular complications but recent data have demonstrated improvements in macrovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhi...

Szczegółowa specyfikacja

Zapisane w:

Opis bibliograficzny
Główni autorzy:	Joel C Marrs (Autor), Sarah L Anderson (Autor)
Format:	Książka
Wydane:	BioExcel Publishing Ltd, 2020-11-01T00:00:00Z.
Hasła przedmiotowe:	article
Dostęp online:	Connect to this object online.
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Tirzepatide for type 2 diabetes
od: Sarah L Anderson, i wsp.
Wydane: (2023)

Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date
od: Cinti F, i wsp.
Wydane: (2017)

Efficacy and Safety of Ertugliflozin in Type 2 Diabetes: A Systematic Review and Meta-Analysis
od: Li Liu, i wsp.
Wydane: (2022)

Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
od: Derosa G, i wsp.
Wydane: (2018)

Diabetes: how to manage cardiovascular risk in secondary prevention patients
od: Sarah L Anderson, i wsp.
Wydane: (2022)

Inclisiran for the treatment of hypercholesterolaemia
od: Joel C Marrs, i wsp.
Wydane: (2024)

Bempedoic acid for the treatment of dyslipidemia
od: Joel C Marrs, i wsp.
Wydane: (2020)

Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment
od: Sarah L Anderson, i wsp.
Wydane: (2018)

Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
od: Sunitha Gurrala, i wsp.
Wydane: (2023)

Examining the Impact of Ertugliflozin on Cardiovascular Outcomes in Patients with Diabetes and Metabolic Syndrome: A Systematic Review of Clinical Trials
od: Silvius Alexandru Pescariu, i wsp.
Wydane: (2024)

Use of Ayurveda in the Treatment of Type 2 Diabetes Mellitus
od: Allison Gordon MD Candidate, i wsp.
Wydane: (2019)

Trends of nanotechnology in type 2 diabetes mellitus treatment
od: Yannis V. Simos, i wsp.
Wydane: (2021)

Contributions of no pharmacological treatment for Diabetes Mellitus Type 2.
od: Silas Santos Carvalho, i wsp.
Wydane: (2015)

End‐to‐end application of model‐informed drug development for ertugliflozin, a novel sodium‐glucose cotransporter 2 inhibitor
od: Daryl J. Fediuk, i wsp.
Wydane: (2021)

Dyslipidemia in Type 2 Diabetes mellitus
od: Subarna Dhoj Thapa, i wsp.
Wydane: (2017)

Paradigm shift in the pharmacological treatment of type 2 diabetes mellitus
od: Tejal Lathia
Wydane: (2020)

Physical activity in prevention and treatment of type 2 diabetes mellitus
od: Monika Klimek, i wsp.
Wydane: (2019)

Physical activity in prevention and treatment of type 2 diabetes mellitus
od: Monika Klimek, i wsp.
Wydane: (2019)

Novel stability-indicating RP-UPLC method for simultaneous estimation of sitagliptin and ertugliflozin in bulk and pharmaceutical formulations
od: Ramya kuber B, i wsp.
Wydane: (2021)

HYPERTENSION AND DIABETES MELLITUS TYPE 2
od: M. E. Statsenko, i wsp.
Wydane: (2018)

Dyslipidemia in type 2 diabetes mellitus
od: Stefanović Aleksandra, i wsp.
Wydane: (2019)

Betatrophin in type 2 diabetes mellitus
od: Omprakash Gupta
Wydane: (2013)

SGLT2 inhibitors for treatment of Type 2 diabetes mellitus: Focus on Canagliflozin
od: Santosh Kumar Singh, i wsp.
Wydane: (2014)

SGLT2 inhibitors for treatment of Type 2 diabetes mellitus: Focus on Canagliflozin
od: Santosh Kumar Singh, i wsp.
Wydane: (2014)

Laparoscopic sleeve gastrectomy for treatment of type 2 diabetes mellitus in adolescents
od: Mohamed Saber Mostafa, i wsp.
Wydane: (2022)

The influence of methods of bariatric surgery for treatment of type 2 diabetes mellitus
od: Bužga M, i wsp.
Wydane: (2016)

Health literacy and adherence to drug treatment of type 2 diabetes mellitus
od: Mariana Rodrigues da Rocha, i wsp.
Wydane: (2019)

Prevalence of Type 2 Diabetes Mellitus and Adherence to Anti Diabetic Treatment in an Urban Population
od: Markordor Lyngdoh, i wsp.
Wydane: (2021)

Stability indicating method development and validation for simultaneous estimation and quantification of Ertugliflozin and Metformin in bulk and tablet dosage form
od: Bhawani Sunkara, i wsp.
Wydane: (2021)

Ultrasound therapy of diabetes mellitus type 2
od: I. Samosiuk, i wsp.
Wydane: (2011)

Green tea and type 2 diabetes mellitus
od: Rafieian-Kopaei Mahmoud, i wsp.
Wydane: (2014)

Vitamin D in Type 2 Diabetes Mellitus
od: Sandra Martínez-Pizarro
Wydane: (2024)

Advances in the management of type 2 diabetes mellitus
od: Nariman Moustafa
Wydane: (2012)

Type 2 Diabetes Mellitus and Cognitive Impairment
od: Johanda Damanik, i wsp.
Wydane: (2021)

Serum visfatin in type 2 diabetes mellitus
od: Samiha A. Abd Rabo, i wsp.
Wydane: (2013)

Prevalence of hypertension in type-2 diabetes mellitus
od: K Venugopal, i wsp.
Wydane: (2014)

DIABETES MELLITUS TYPE 2 TREATMENT IN CHILDREN AND ADOLESCENTS: METFORMIN AS A FIRST AGENT OF CHOICE
od: T. L. Kuraeva
Wydane: (2012)

Development and validation of stability-indicating RP-HPLC method for the simultaneous determination of ertugliflozin pidolate and metformin hydrochloride in bulk and tablets
od: K. Sravana Kumari, i wsp.
Wydane: (2020)

The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus
od: T. Yu. Demidova, i wsp.
Wydane: (2020)

The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus
od: Ya-yi Jiang, i wsp.
Wydane: (2020)